• Blueprint Medicines Co. (NASDAQ:BPMC) Given Consensus Recommendation of "Moderate Buy" by Analysts

    Source: Buzz FX / 21 Mar 2025 02:26:17   America/New_York


    Blueprint Medicines Co. (NASDAQ:BPMC) Given Consensus Recommendation of "Moderate Buy" by Analysts Written by MarketBeat March 21, 2025 Share Link copied to clipboard. Remove Ads Shares of Blueprint Medicines Co.
    Read more...
Share on,